An	O
attenuated	O
Mycobacterium	B:C0026926
tuberculosis	I:C0026926
clinical	O
strain	O
with	O
a	O
defect	O
in	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	O
induces	O
minimal	O
host	O
immune	O
responses	I:C0301872
and	O
pathology	O
.	O

An	O
attenuated	O
Mycobacterium	O
tuberculosis	I:C0026926
clinical	O
strain	O
with	O
a	O
defect	O
in	O
ESX	B:C1744314
-	I:C1744314
1	I:C1744314
secretion	O
induces	O
minimal	O
host	O
immune	O
responses	I:C0301872
and	O
pathology	O
.	O

An	O
attenuated	O
Mycobacterium	O
tuberculosis	I:C0026926
clinical	O
strain	O
with	O
a	O
defect	O
in	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	B:C0036536
induces	O
minimal	O
host	O
immune	O
responses	I:C0301872
and	O
pathology	O
.	O

An	O
attenuated	O
Mycobacterium	O
tuberculosis	I:C0026926
clinical	O
strain	O
with	O
a	O
defect	O
in	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	O
induces	O
minimal	O
host	O
immune	B:C0301872
responses	I:C0301872
and	O
pathology	O
.	O

An	O
attenuated	O
Mycobacterium	O
tuberculosis	I:C0026926
clinical	O
strain	O
with	O
a	O
defect	O
in	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	O
induces	O
minimal	O
host	O
immune	O
responses	I:C0301872
and	O
pathology	B:C0030664
.	O

Although	O
Mycobacterium	B:C0026926
tuberculosis	I:C0026926
(	I:C0026926
M.tb	I:C0026926
)	I:C0026926
DK9897	I:C0026926
is	O
an	O
attenuated	O
strain	O
,	O
it	O
was	O
isolated	O
from	O
a	O
patient	O
with	O
extrapulmonary	O
tuberculosis	I:C0679362
and	O
vaccination	O
with	O
a	O
subunit	O
vaccine	I:C0887892
(	O
H56	O
)	O
induced	O
poor	O
protection	O
against	O
it	O
.	O

Although	O
Mycobacterium	O
tuberculosis	I:C0026926
(	I:C0026926
M.tb	I:C0026926
)	I:C0026926
DK9897	I:C0026926
is	O
an	O
attenuated	O
strain	O
,	O
it	O
was	O
isolated	O
from	O
a	O
patient	O
with	O
extrapulmonary	B:C0679362
tuberculosis	I:C0679362
and	O
vaccination	O
with	O
a	O
subunit	O
vaccine	I:C0887892
(	O
H56	O
)	O
induced	O
poor	O
protection	O
against	O
it	O
.	O

Although	O
Mycobacterium	O
tuberculosis	I:C0026926
(	I:C0026926
M.tb	I:C0026926
)	I:C0026926
DK9897	I:C0026926
is	O
an	O
attenuated	O
strain	O
,	O
it	O
was	O
isolated	O
from	O
a	O
patient	O
with	O
extrapulmonary	O
tuberculosis	I:C0679362
and	O
vaccination	B:C0042196
with	O
a	O
subunit	O
vaccine	I:C0887892
(	O
H56	O
)	O
induced	O
poor	O
protection	O
against	O
it	O
.	O

Although	O
Mycobacterium	O
tuberculosis	I:C0026926
(	I:C0026926
M.tb	I:C0026926
)	I:C0026926
DK9897	I:C0026926
is	O
an	O
attenuated	O
strain	O
,	O
it	O
was	O
isolated	O
from	O
a	O
patient	O
with	O
extrapulmonary	O
tuberculosis	I:C0679362
and	O
vaccination	O
with	O
a	O
subunit	B:C0887892
vaccine	I:C0887892
(	O
H56	O
)	O
induced	O
poor	O
protection	O
against	O
it	O
.	O

Although	O
Mycobacterium	O
tuberculosis	I:C0026926
(	I:C0026926
M.tb	I:C0026926
)	I:C0026926
DK9897	I:C0026926
is	O
an	O
attenuated	O
strain	O
,	O
it	O
was	O
isolated	O
from	O
a	O
patient	O
with	O
extrapulmonary	O
tuberculosis	I:C0679362
and	O
vaccination	O
with	O
a	O
subunit	O
vaccine	I:C0887892
(	O
H56	B:C0887892
)	O
induced	O
poor	O
protection	O
against	O
it	O
.	O

Both	O
attenuation	O
and	O
lack	O
of	O
protection	O
are	O
because	O
M.tb	B:C0026926
DK9897	I:C0026926
cannot	O
secrete	O
the	O
EsxA	O
virulence	O
factor	I:C1136170
nor	O
induce	O
a	O
host	O
response	I:C0301872
against	O
it	O
.	O

Both	O
attenuation	O
and	O
lack	O
of	O
protection	O
are	O
because	O
M.tb	O
DK9897	I:C0026926
cannot	O
secrete	B:C0036536
the	O
EsxA	O
virulence	O
factor	I:C1136170
nor	O
induce	O
a	O
host	O
response	I:C0301872
against	O
it	O
.	O

Both	O
attenuation	O
and	O
lack	O
of	O
protection	O
are	O
because	O
M.tb	O
DK9897	I:C0026926
cannot	O
secrete	O
the	O
EsxA	B:C1744314
virulence	O
factor	I:C1136170
nor	O
induce	O
a	O
host	O
response	I:C0301872
against	O
it	O
.	O

Both	O
attenuation	O
and	O
lack	O
of	O
protection	O
are	O
because	O
M.tb	O
DK9897	I:C0026926
cannot	O
secrete	O
the	O
EsxA	O
virulence	B:C1136170
factor	I:C1136170
nor	O
induce	O
a	O
host	O
response	I:C0301872
against	O
it	O
.	O

Both	O
attenuation	O
and	O
lack	O
of	O
protection	O
are	O
because	O
M.tb	O
DK9897	I:C0026926
cannot	O
secrete	O
the	O
EsxA	O
virulence	O
factor	I:C1136170
nor	O
induce	O
a	O
host	B:C0301872
response	I:C0301872
against	O
it	O
.	O

Genome	O
sequencing	O
identified	O
a	O
frameshift	B:C0079380
mutation	I:C0079380
in	O
the	O
eccCa1	O
gene	I:C0017337
.	O

Genome	O
sequencing	O
identified	O
a	O
frameshift	O
mutation	I:C0079380
in	O
the	O
eccCa1	B:C0017337
gene	I:C0017337
.	O

Since	O
the	O
encoded	O
EccCa1	B:C1254349
protein	I:C1254349
provides	O
energy	O
for	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	O
,	O
it	O
suggested	O
a	O
defect	O
in	O
the	O
ESX	O
-	I:C1744314
1	I:C1744314
type	O
VII	I:C3159197
secretion	I:C3159197
system	I:C3159197
.	O

Since	O
the	O
encoded	O
EccCa1	O
protein	I:C1254349
provides	O
energy	O
for	O
ESX	B:C1744314
-	I:C1744314
1	I:C1744314
secretion	O
,	O
it	O
suggested	O
a	O
defect	O
in	O
the	O
ESX	O
-	I:C1744314
1	I:C1744314
type	O
VII	I:C3159197
secretion	I:C3159197
system	I:C3159197
.	O

Since	O
the	O
encoded	O
EccCa1	O
protein	I:C1254349
provides	O
energy	O
for	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	B:C0036536
,	O
it	O
suggested	O
a	O
defect	O
in	O
the	O
ESX	O
-	I:C1744314
1	I:C1744314
type	O
VII	I:C3159197
secretion	I:C3159197
system	I:C3159197
.	O

Since	O
the	O
encoded	O
EccCa1	O
protein	I:C1254349
provides	O
energy	O
for	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	O
,	O
it	O
suggested	O
a	O
defect	O
in	O
the	O
ESX	B:C1744314
-	I:C1744314
1	I:C1744314
type	O
VII	I:C3159197
secretion	I:C3159197
system	I:C3159197
.	O

Since	O
the	O
encoded	O
EccCa1	O
protein	I:C1254349
provides	O
energy	O
for	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	O
,	O
it	O
suggested	O
a	O
defect	O
in	O
the	O
ESX	O
-	I:C1744314
1	I:C1744314
type	B:C3159197
VII	I:C3159197
secretion	I:C3159197
system	I:C3159197
.	O

Genetic	O
complementation	O
with	O
a	O
plasmid	B:C0032136
carrying	O
the	O
M.tb	O
H37Rv	I:C0026926
sequence	O
of	O
eccCa1	O
-	I:C0012931
eccCb1	I:C0012931
-	I:C0012931
pe35	I:C0012931
re-established	O
EsxA	O
secretion	O
,	O
host	O
specific	O
EsxA	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
,	O
and	O
increased	O
strain	O
virulence	O
.	O

Genetic	O
complementation	O
with	O
a	O
plasmid	O
carrying	O
the	O
M.tb	B:C0026926
H37Rv	I:C0026926
sequence	O
of	O
eccCa1	O
-	I:C0012931
eccCb1	I:C0012931
-	I:C0012931
pe35	I:C0012931
re-established	O
EsxA	O
secretion	O
,	O
host	O
specific	O
EsxA	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
,	O
and	O
increased	O
strain	O
virulence	O
.	O

Genetic	O
complementation	O
with	O
a	O
plasmid	O
carrying	O
the	O
M.tb	O
H37Rv	I:C0026926
sequence	O
of	O
eccCa1	B:C0012931
-	I:C0012931
eccCb1	I:C0012931
-	I:C0012931
pe35	I:C0012931
re-established	O
EsxA	O
secretion	O
,	O
host	O
specific	O
EsxA	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
,	O
and	O
increased	O
strain	O
virulence	O
.	O

Genetic	O
complementation	O
with	O
a	O
plasmid	O
carrying	O
the	O
M.tb	O
H37Rv	I:C0026926
sequence	O
of	O
eccCa1	O
-	I:C0012931
eccCb1	I:C0012931
-	I:C0012931
pe35	I:C0012931
re-established	O
EsxA	B:C1744314
secretion	O
,	O
host	O
specific	O
EsxA	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
,	O
and	O
increased	O
strain	O
virulence	O
.	O

Genetic	O
complementation	O
with	O
a	O
plasmid	O
carrying	O
the	O
M.tb	O
H37Rv	I:C0026926
sequence	O
of	O
eccCa1	O
-	I:C0012931
eccCb1	I:C0012931
-	I:C0012931
pe35	I:C0012931
re-established	O
EsxA	O
secretion	B:C0036536
,	O
host	O
specific	O
EsxA	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
,	O
and	O
increased	O
strain	O
virulence	O
.	O

Genetic	O
complementation	O
with	O
a	O
plasmid	O
carrying	O
the	O
M.tb	O
H37Rv	I:C0026926
sequence	O
of	O
eccCa1	O
-	I:C0012931
eccCb1	I:C0012931
-	I:C0012931
pe35	I:C0012931
re-established	O
EsxA	O
secretion	O
,	O
host	O
specific	O
EsxA	B:C1744314
T	O
-	I:C0039194
cell	I:C0039194
responses	O
,	O
and	O
increased	O
strain	O
virulence	O
.	O

Genetic	O
complementation	O
with	O
a	O
plasmid	O
carrying	O
the	O
M.tb	O
H37Rv	I:C0026926
sequence	O
of	O
eccCa1	O
-	I:C0012931
eccCb1	I:C0012931
-	I:C0012931
pe35	I:C0012931
re-established	O
EsxA	O
secretion	O
,	O
host	O
specific	O
EsxA	O
T	B:C0039194
-	I:C0039194
cell	I:C0039194
responses	O
,	O
and	O
increased	O
strain	O
virulence	O
.	O

Genetic	O
complementation	O
with	O
a	O
plasmid	O
carrying	O
the	O
M.tb	O
H37Rv	I:C0026926
sequence	O
of	O
eccCa1	O
-	I:C0012931
eccCb1	I:C0012931
-	I:C0012931
pe35	I:C0012931
re-established	O
EsxA	O
secretion	O
,	O
host	O
specific	O
EsxA	O
T	O
-	I:C0039194
cell	I:C0039194
responses	B:C0301872
,	O
and	O
increased	O
strain	O
virulence	O
.	O

Genetic	O
complementation	O
with	O
a	O
plasmid	O
carrying	O
the	O
M.tb	O
H37Rv	I:C0026926
sequence	O
of	O
eccCa1	O
-	I:C0012931
eccCb1	I:C0012931
-	I:C0012931
pe35	I:C0012931
re-established	O
EsxA	O
secretion	O
,	O
host	O
specific	O
EsxA	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
,	O
and	O
increased	O
strain	O
virulence	B:C0042765
.	O

The	O
ESX	B:C1744314
-	I:C1744314
1	I:C1744314
secretion	O
defect	O
prevents	O
several	O
virulence	O
factors	I:C1136170
from	O
being	O
functional	O
during	O
infection	O
and	O
therefore	O
attenuates	O
Mycobacterium	O
tuberculosis	I:C0026926
.	O

The	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	B:C0036536
defect	O
prevents	O
several	O
virulence	O
factors	I:C1136170
from	O
being	O
functional	O
during	O
infection	O
and	O
therefore	O
attenuates	O
Mycobacterium	O
tuberculosis	I:C0026926
.	O

The	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	O
defect	O
prevents	O
several	O
virulence	B:C1136170
factors	I:C1136170
from	O
being	O
functional	O
during	O
infection	O
and	O
therefore	O
attenuates	O
Mycobacterium	O
tuberculosis	I:C0026926
.	O

The	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	O
defect	O
prevents	O
several	O
virulence	O
factors	I:C1136170
from	O
being	O
functional	O
during	O
infection	B:C3714514
and	O
therefore	O
attenuates	O
Mycobacterium	O
tuberculosis	I:C0026926
.	O

The	O
ESX	O
-	I:C1744314
1	I:C1744314
secretion	O
defect	O
prevents	O
several	O
virulence	O
factors	I:C1136170
from	O
being	O
functional	O
during	O
infection	O
and	O
therefore	O
attenuates	O
Mycobacterium	B:C0026926
tuberculosis	I:C0026926
.	O

It	O
precludes	O
specific	O
T	B:C0039194
-	I:C0039194
cell	I:C0039194
responses	O
against	O
strong	O
antigens	O
and	O
we	O
found	O
very	O
little	O
in	O
vivo	I:C1515655
cytokine	O
production	I:C1327413
,	O
gross	O
pathology	I:C0428094
or	O
granuloma	O
formation	I:C1817882
in	O
lungs	O
from	O
M.tb	O
DK9897	I:C0026926
infected	O
animals	O
.	O

It	O
precludes	O
specific	O
T	O
-	I:C0039194
cell	I:C0039194
responses	B:C0301872
against	O
strong	O
antigens	O
and	O
we	O
found	O
very	O
little	O
in	O
vivo	I:C1515655
cytokine	O
production	I:C1327413
,	O
gross	O
pathology	I:C0428094
or	O
granuloma	O
formation	I:C1817882
in	O
lungs	O
from	O
M.tb	O
DK9897	I:C0026926
infected	O
animals	O
.	O

It	O
precludes	O
specific	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
against	O
strong	O
antigens	B:C0003320
and	O
we	O
found	O
very	O
little	O
in	O
vivo	I:C1515655
cytokine	O
production	I:C1327413
,	O
gross	O
pathology	I:C0428094
or	O
granuloma	O
formation	I:C1817882
in	O
lungs	O
from	O
M.tb	O
DK9897	I:C0026926
infected	O
animals	O
.	O

It	O
precludes	O
specific	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
against	O
strong	O
antigens	O
and	O
we	O
found	O
very	O
little	O
in	B:C1515655
vivo	I:C1515655
cytokine	O
production	I:C1327413
,	O
gross	O
pathology	I:C0428094
or	O
granuloma	O
formation	I:C1817882
in	O
lungs	O
from	O
M.tb	O
DK9897	I:C0026926
infected	O
animals	O
.	O

It	O
precludes	O
specific	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
against	O
strong	O
antigens	O
and	O
we	O
found	O
very	O
little	O
in	O
vivo	I:C1515655
cytokine	B:C1327413
production	I:C1327413
,	O
gross	O
pathology	I:C0428094
or	O
granuloma	O
formation	I:C1817882
in	O
lungs	O
from	O
M.tb	O
DK9897	I:C0026926
infected	O
animals	O
.	O

It	O
precludes	O
specific	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
against	O
strong	O
antigens	O
and	O
we	O
found	O
very	O
little	O
in	O
vivo	I:C1515655
cytokine	O
production	I:C1327413
,	O
gross	B:C0428094
pathology	I:C0428094
or	O
granuloma	O
formation	I:C1817882
in	O
lungs	O
from	O
M.tb	O
DK9897	I:C0026926
infected	O
animals	O
.	O

It	O
precludes	O
specific	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
against	O
strong	O
antigens	O
and	O
we	O
found	O
very	O
little	O
in	O
vivo	I:C1515655
cytokine	O
production	I:C1327413
,	O
gross	O
pathology	I:C0428094
or	O
granuloma	B:C1817882
formation	I:C1817882
in	O
lungs	O
from	O
M.tb	O
DK9897	I:C0026926
infected	O
animals	O
.	O

It	O
precludes	O
specific	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
against	O
strong	O
antigens	O
and	O
we	O
found	O
very	O
little	O
in	O
vivo	I:C1515655
cytokine	O
production	I:C1327413
,	O
gross	O
pathology	I:C0428094
or	O
granuloma	O
formation	I:C1817882
in	O
lungs	B:C0024109
from	O
M.tb	O
DK9897	I:C0026926
infected	O
animals	O
.	O

It	O
precludes	O
specific	O
T	O
-	I:C0039194
cell	I:C0039194
responses	O
against	O
strong	O
antigens	O
and	O
we	O
found	O
very	O
little	O
in	O
vivo	I:C1515655
cytokine	O
production	I:C1327413
,	O
gross	O
pathology	I:C0428094
or	O
granuloma	O
formation	I:C1817882
in	O
lungs	O
from	O
M.tb	B:C0026926
DK9897	I:C0026926
infected	O
animals	O
.	O

This	O
coincides	O
with	O
M.tb	B:C0026926
DK9897	I:C0026926
being	O
unable	O
to	O
disrupt	O
the	O
phagosome	O
membrane	I:C1166752
and	O
make	O
contact	O
to	O
the	O
cytosol	O
.	O

This	O
coincides	O
with	O
M.tb	O
DK9897	I:C0026926
being	O
unable	O
to	O
disrupt	O
the	O
phagosome	B:C1166752
membrane	I:C1166752
and	O
make	O
contact	O
to	O
the	O
cytosol	O
.	O

This	O
coincides	O
with	O
M.tb	O
DK9897	I:C0026926
being	O
unable	O
to	O
disrupt	O
the	O
phagosome	O
membrane	I:C1166752
and	O
make	O
contact	O
to	O
the	O
cytosol	B:C1383501
.	O

